Galmed Pharmaceuticals Ltd. (GPH)
Market Open
5 Jun, 06:01
XFRA 
NASDAQ (CM) Primary XFRA €
2. 74
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
-1.29 Eps
€ 2.74
Previous Close Want to track GPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
GPH Earnings Reports FAQ
What is the earnings per share (EPS) for GPH?
The current EPS is -1.29.
What is the company's earnings growth rate?
Galmed Pharmaceuticals Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Galmed Pharmaceuticals Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Galmed Pharmaceuticals Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GPH at this time, as Galmed Pharmaceuticals Ltd has no recent EPS data to calculate it.
